Literature DB >> 35113359

Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.

Manoj Kumar1, Zaigham Abbas2, Milad Azami3, Maria Belopolskaya4, A K Dokmeci5, Hasmik Ghazinyan6, Jidong Jia7, Ankur Jindal8, Han Chu Lee9, Wei Lei10, Seng Gee Lim11, Chun-Jen Liu12, Qiang Li13, Mamun Al Mahtab14, David H Muljono15, Madunil Anuk Niriella16, Masao Omata17,18, Diana A Payawal19, Shiv K Sarin20, Olivier Ségéral21, Tawesak Tanwandee22, Nirupma Trehanpati23, Kumar Visvanathan24, Jin Mo Yang25, Man-Fung Yuen26, Yingjie Zheng27, Y H Zhou28.   

Abstract

Hepatitis B virus (HBV) infection still remains a major public health issue in the Asia-Pacific region. Most of the burden of HBV-related disease results from infections acquired in infancy through perinatal or early childhood exposure to HBV in Asia-Pacific. Hepatitis B during pregnancy presents unique management issues for both the mother and fetus. These APASL guidelines provide a comprehensive review and recommendations based on available evidence in the literature, for the management of females with HBV infection through every stage of pregnancy and postpartum. These also address the concerns, management challenges, and required follow-up of children born to hepatitis B-positive mothers.
© 2022. Asian Pacific Association for the Study of the Liver.

Entities:  

Keywords:  Acute Hepatitis B; Chronic Hepatitis B; Hepatitis B; Pregnancy

Mesh:

Substances:

Year:  2022        PMID: 35113359     DOI: 10.1007/s12072-021-10285-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   9.029


  2 in total

1.  Inhibition of In Vitro Infection of Hepatitis B Virus by Human Breastmilk.

Authors:  Yuqian Luo; Kuanhui Xiang; Jingli Liu; Ji Song; Jing Feng; Jie Chen; Yimin Dai; Yali Hu; Hui Zhuang; Yihua Zhou
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

Review 2.  Current treatment of chronic hepatitis B: Clinical aspects and future directions.

Authors:  Minmin Zhu; Hui Wang; Tao Lou; Pian Xiong; Jiebing Zhang; Lele Li; Yuchao Sun; Yingping Wu
Journal:  Front Microbiol       Date:  2022-09-08       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.